Skip to main content
Holiday Sale — Get 40% off Vantage for yourself or as a gift
Published loading...Updated

Peru Participates in Clinical Trials for an Hiv Vaccine From San Marcos

Summary by Diario Correo
Peru has joined international efforts to develop a vaccine against human immunodeficiency virus (HIV).At the Universidad Nacional Mayor de San Marcos (UNMSM), a team of researchers conducts clinical trials and preventive treatment studies as part of a global scientific network.These investigations are carried out at the Center for Technological, Biomedical and Environmental Research (CITBM), through its Clinical Trials Unit (UNIDEC), responsible…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.Cross Cancel Icon

1 Articles

Peru has joined international efforts to develop a vaccine against human immunodeficiency virus (HIV).At the Universidad Nacional Mayor de San Marcos (UNMSM), a team of researchers conducts clinical trials and preventive treatment studies as part of a global scientific network.These investigations are carried out at the Center for Technological, Biomedical and Environmental Research (CITBM), through its Clinical Trials Unit (UNIDEC), responsible…

·Peru
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Diario Correo broke the news in Peru on Monday, December 15, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal